379 related articles for article (PubMed ID: 25385595)
21. Conformational flexibility underlies ubiquitin ligation mediated by the WWP1 HECT domain E3 ligase.
Verdecia MA; Joazeiro CA; Wells NJ; Ferrer JL; Bowman ME; Hunter T; Noel JP
Mol Cell; 2003 Jan; 11(1):249-59. PubMed ID: 12535537
[TBL] [Abstract][Full Text] [Related]
22. UbFluor: A Fluorescent Thioester to Monitor HECT E3 Ligase Catalysis.
Krist DT; Foote PK; Statsyuk AV
Curr Protoc Chem Biol; 2017 Mar; 9(1):11-37. PubMed ID: 28253433
[TBL] [Abstract][Full Text] [Related]
23. Functional significance and therapeutic implication of ring-type E3 ligases in colorectal cancer.
Liu L; Wong CC; Gong B; Yu J
Oncogene; 2018 Jan; 37(2):148-159. PubMed ID: 28925398
[TBL] [Abstract][Full Text] [Related]
24. Developing Small-Molecule Inhibitors of HECT-Type Ubiquitin Ligases for Therapeutic Applications: Challenges and Opportunities.
Chen D; Gehringer M; Lorenz S
Chembiochem; 2018 Oct; 19(20):2123-2135. PubMed ID: 30088849
[TBL] [Abstract][Full Text] [Related]
25. HECT E3 ubiquitin ligases - emerging insights into their biological roles and disease relevance.
Wang Y; Argiles-Castillo D; Kane EI; Zhou A; Spratt DE
J Cell Sci; 2020 Apr; 133(7):. PubMed ID: 32265230
[TBL] [Abstract][Full Text] [Related]
26. High throughput screening for inhibitors of the HECT ubiquitin E3 ligase ITCH identifies antidepressant drugs as regulators of autophagy.
Rossi M; Rotblat B; Ansell K; Amelio I; Caraglia M; Misso G; Bernassola F; Cavasotto CN; Knight RA; Ciechanover A; Melino G
Cell Death Dis; 2014 May; 5(5):e1203. PubMed ID: 24787015
[TBL] [Abstract][Full Text] [Related]
27. Tobramycin suppresses HUWE1 degradation to control MCL-1 stability during tumour development.
He J; Wu S; Li X; Tang L; Chen H; Qin L; Xie J; Lu T; Xu W
Clin Exp Pharmacol Physiol; 2020 Sep; 47(9):1600-1610. PubMed ID: 32378766
[TBL] [Abstract][Full Text] [Related]
28. The HECT family of E3 ubiquitin ligases: multiple players in cancer development.
Bernassola F; Karin M; Ciechanover A; Melino G
Cancer Cell; 2008 Jul; 14(1):10-21. PubMed ID: 18598940
[TBL] [Abstract][Full Text] [Related]
29. An activity-based probe developed by a sequential dehydroalanine formation strategy targets HECT E3 ubiquitin ligases.
Xu L; Fan J; Wang Y; Zhang Z; Fu Y; Li YM; Shi J
Chem Commun (Camb); 2019 Jun; 55(49):7109-7112. PubMed ID: 31157339
[TBL] [Abstract][Full Text] [Related]
30. Development and characterisation of SMURF2-targeting modifiers.
Manikoth Ayyathan D; Levy-Cohen G; Shubely M; Boutros-Suleiman S; Lepechkin-Zilbermintz V; Shokhen M; Albeck A; Gruzman A; Blank M
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):401-409. PubMed ID: 33430646
[TBL] [Abstract][Full Text] [Related]
31. HECT ubiquitin ligases link viral and cellular PPXY motifs to the vacuolar protein-sorting pathway.
Martin-Serrano J; Eastman SW; Chung W; Bieniasz PD
J Cell Biol; 2005 Jan; 168(1):89-101. PubMed ID: 15623582
[TBL] [Abstract][Full Text] [Related]
32. Regulation of Nedd4-2 self-ubiquitination and stability by a PY motif located within its HECT-domain.
Bruce MC; Kanelis V; Fouladkou F; Debonneville A; Staub O; Rotin D
Biochem J; 2008 Oct; 415(1):155-63. PubMed ID: 18498246
[TBL] [Abstract][Full Text] [Related]
33. Overview of approaches for screening for ubiquitin ligase inhibitors.
Sun Y
Methods Enzymol; 2005; 399():654-63. PubMed ID: 16338387
[TBL] [Abstract][Full Text] [Related]
34. The WW1 Domain Enhances Autoinhibition in Smurf Ubiquitin Ligases.
Ruetalo N; Anders S; Stollmaier C; Jäckl M; Schütz-Stoffregen MC; Stefan N; Wolf C; Wiesner S
J Mol Biol; 2019 Dec; 431(24):4834-4847. PubMed ID: 31628949
[TBL] [Abstract][Full Text] [Related]
35. The HECT domain of TRIP12 ubiquitinates substrates of the ubiquitin fusion degradation pathway.
Park Y; Yoon SK; Yoon JB
J Biol Chem; 2009 Jan; 284(3):1540-9. PubMed ID: 19028681
[TBL] [Abstract][Full Text] [Related]
36. A Small Molecule That Switches a Ubiquitin Ligase From a Processive to a Distributive Enzymatic Mechanism.
Kathman SG; Span I; Smith AT; Xu Z; Zhan J; Rosenzweig AC; Statsyuk AV
J Am Chem Soc; 2015 Oct; 137(39):12442-5. PubMed ID: 26371805
[TBL] [Abstract][Full Text] [Related]
37. Regulation of catalytic activities of HECT ubiquitin ligases.
Kee Y; Huibregtse JM
Biochem Biophys Res Commun; 2007 Mar; 354(2):329-33. PubMed ID: 17240353
[TBL] [Abstract][Full Text] [Related]
38. System-Wide Modulation of HECT E3 Ligases with Selective Ubiquitin Variant Probes.
Zhang W; Wu KP; Sartori MA; Kamadurai HB; Ordureau A; Jiang C; Mercredi PY; Murchie R; Hu J; Persaud A; Mukherjee M; Li N; Doye A; Walker JR; Sheng Y; Hao Z; Li Y; Brown KR; Lemichez E; Chen J; Tong Y; Harper JW; Moffat J; Rotin D; Schulman BA; Sidhu SS
Mol Cell; 2016 Apr; 62(1):121-36. PubMed ID: 26949039
[TBL] [Abstract][Full Text] [Related]
39. The Role of HECT-Type E3 Ligase in the Development of Cardiac Disease.
Goto J; Otaki Y; Watanabe T; Watanabe M
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34199773
[TBL] [Abstract][Full Text] [Related]
40. Solenoid architecture of HUWE1 contributes to ligase activity and substrate recognition.
Hunkeler M; Jin CY; Ma MW; Monda JK; Overwijn D; Bennett EJ; Fischer ES
Mol Cell; 2021 Sep; 81(17):3468-3480.e7. PubMed ID: 34314700
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
